Bilaketaren emaitzak - Gary Middleton

Findu emaitzak
  1. 1
    The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

    The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies nork Leisha A. Emens, Gary Middleton

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review

    The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review nork Taylor Fulton-Ward, Gary Middleton

    Argitaratua 2023
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

    The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer nork Akshay J. Patel, Alex Richter, Mark T. Drayson, Gary Middleton

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer

    A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer nork Gary Middleton, Helen L. Robbins, Fabrice André, Charles Swanton

    Argitaratua 2021
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy

    An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy nork Neeraj Lal, Andrew D. Beggs, Benjamin E. Willcox, Gary Middleton

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Mechanisms of immunogenicity in colorectal cancer

    Mechanisms of immunogenicity in colorectal cancer nork Toritseju O. Sillo, Andrew D. Beggs, Dion Morton, Gary Middleton

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

    Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2... nork Rachel F. Gabitass, Nicola Annels, Deborah Stocken, Hardev Pandha, Gary Middleton

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications

    A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications nork Akshay J. Patel, Ti-Myen Tan, Alex Richter, Babu Naidu, Jonathan M. Blackburn, Gary Middleton

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

    Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. nork Marian Ludgate, Anthony McGregor, A P Weetman, Suvina Ratanachaiyavong, John H. Lazarus, R. Hall, Gary Middleton

    Argitaratua 1984
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

    Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease nork Crispin T. Hiley, John Le Quesne, George Santis, Rowena Sharpe, David González de Castro, Gary Middleton, Charles Swanton

    Argitaratua 2016
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

    Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer nork David Cunningham, Naureen Starling, Sheela Rao, Timothy Iveson, M. Nicolson, Fareeda Y. Coxon, Gary Middleton, Francis Daniel, J. Oates, A. Norman

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group

    Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National... nork Naureen Starling, Sheela Rao, David Cunningham, Timothy Iveson, M. Nicolson, Fareeda Y. Coxon, Gary Middleton, Francis Daniel, J. Oates, A. Norman

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

    The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer nork Gary Middleton, L. Crack, Sanjay Popat, Charles Swanton, Simon J. Hollingsworth, R. Buller, Ian Walker, T. Hedley Carr, Dee Wherton, Lucinda Billingham

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

    Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants nork Valerie Pestinger, Matthew Ryan Smith, Toju Sillo, John M. Findlay, Jean‐François Laes, Gerald Martin, Gary Middleton, Phillipe Taniere, Andrew D. Beggs

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer

    KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer nork Neeraj Lal, Brian S. White, Ghaleb Goussous, Oliver Pickles, Mike J. Mason, Andrew D. Beggs, Philippe Tanière, Benjamin E. Willcox, Justin Guinney, Gary Middleton

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

    Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial nork Michel Seymour, Lindsay C Thompson, Harpreet Wasan, Gary Middleton, A. Brewster, Stephen F Shepherd, M. S. O'Mahony, Tim Maughan, Mahesh Parmar, Ruth E. Langley

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype

    NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype nork Francesca Marcon, Jianmin Zuo, Hayden Pearce, Samantha M. Nicol, Sandra Margielewska‐Davies, Farhat Mustafa, Brinder Mahon, Gary Middleton, Rachel Brown, Keith Roberts, Paul Moss

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade

    Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade nork Akshay J. Patel, Zena Willsmore, Naeem Khan, Alex Richter, Babu Naidu, Mark T. Drayson, Sophie Papa, Andrew Cope, Sophia N. Karagiannis, Esperanza Perucha, Gary Middleton

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    The dual role of TIGIT in regulatory and effector T cells in chronic liver disease

    The dual role of TIGIT in regulatory and effector T cells in chronic liver disease nork Amber Bozward, Scott Davies, Rémi Fiancette, Grace Wootton, Sian Faustini, Hin Kwok, Naomi Richardson, Sean Michael Morris, Kayani Kayani, Gary Middleton, Ye Htun Oo

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

    Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials nork Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Susan D. Richman, Faye Elliott, Sarah Brown, Richard Adams, Tim Maughan, Philip Quirke, Jeremy P. Cheadle, Michel Seymour, Gary Middleton

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: